55世纪

　　Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Notice of Drug Clinical Trial Approval from the ...

　　Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Noti...

Detailed>>

Detailed +

2022.0122

2022.01.22

Anhui Double-Crane’s Metronidazole and Sodium Chloride Injection Passed the Consistency Evaluation of Quality and ꧙Efficacy of Generic Drugs

Anhui Double-Crane’s Metronidazole and Sodium Ch⛄loride Injection Pass♉e...

　　CR Double-Crane announced on January 22nd that its wholly-owned subsidiary Double-Crane Pharmaceutical (Anhui) received the Approval...

2021.1112

2021.11.12

Novel Canc🔯er Drug of CR Double-Crane Released and the Signing Ceremony between Haikou National Hi-tech Zone 𝓡and CR Double-Crane Convened

Novel Cancer Drꦯug of CR Double-Crane Released and the Signing Ceremony ...

　　At 9: 00 on November 11, 2021, a novel cancer drug was released by CR Double-Crane, and the signing ceremony between the company and...

2021.1009

2021.10.09

NIPꦬ Pharm’s Innovative Drug NIP142 Approved for Clinical Trials for NSCLC

NIP Pharm’s Inno♏v🔥ative Drug NIP142 Approved for Clinical Trials for NSCLC

　　Recently, National Institute of Pharmaceutical R&D Co., Ltd. (NIP Pharm), a subsidiary of CR Pharmaceutical Group, received the Noti...

2021.1008

2021.10.08

55世纪:A Delegation Led by Zhang Boli Visit♔ing CR Sanj📖iu

55世纪:🅰A Delegation Le🗹d by Zhang Boli Visiting CR Sanjiu

　　On October 7, a delegation led by Zhang Boli, an academician with the Chinese Academy of Engineering and recipient of the national h...

2021.0917

2021.09.17

Remaining Committed to Charity - The𒉰 CR Healthy Villag𒊎e Program Keeping up the Good Work

Remaining Commꦡitted to Charity - The CR Healthy Village Program Keeping...

　　The meeting for wrapping up the CR Healthy Village Program with the theme of “Boosting Primary-Level Medical Services and Supportin...

2021.0804

2021.08.04

CR Double-Crane’s💮 Sodium Valꦦproate Tablets Fluconazole and Sodium Chloride Injection Passing Consistency Evaluation of Generic Drugs

CR Double-Crane’s Sodium Valpro🍷ate Tablets Fluconazole and Sodium Chlo...

　　On August 4, CR Double-Crane issued an announcement that the Sodium Valproate Tablets produced by Hunan Xiangzhong Pharmaceutical Co...

2021.0721

2021.07.21

CR Double-Crane and NOVITA signed an 🌺exclusive license agreement on the development, production and commercialization of NP-G2-044 𝓡Fascin inhibitor in Greater China.

CR Double-Crane and NOVITA signed an exclusive license agree๊ment on the...

　　On July 21, CR Double-Crane Pharmaceuticals Co., Ltd (hereinafter referred to as CR Double-Crane), a subsidiary of China Resources P...

var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"}); 55世纪 - 55世纪官网 - 55世纪平台 55世纪 - 55世纪官网55世纪 55世纪app - 55世纪 - 官网登录 55世纪app - 55世纪平台 - 官网入口米乐m6 - 官网登录